| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/14/2000 | WO2000022125A9 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 09/14/2000 | WO2000020452A9 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
| 09/14/2000 | DE19911684A1 Human nucleic acid sequences from endothelial cells useful for treatment of angiogenic disease, including psoriasis, arthritis and diabetic retinopathy, etc |
| 09/14/2000 | CA2367334A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2366713A1 Antibody and chemokine constructs and their use in the treatment of autoimmune diseases |
| 09/14/2000 | CA2366706A1 Mammalian cytokines; related reagents and methods |
| 09/14/2000 | CA2366147A1 Casb618 polynucleotides and polypeptides and their use |
| 09/14/2000 | CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | CA2366101A1 Intact cell assay for protein tyrosine phosphatases |
| 09/14/2000 | CA2366069A1 Generation of conditional yeast mutants, methods and reagents related thereto |
| 09/14/2000 | CA2365904A1 Mitomycin biosynthetic gene cluster |
| 09/14/2000 | CA2364440A1 Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses |
| 09/14/2000 | CA2364435A1 Lactobacillus strains preventing diarrhoea pathogenic bacteria |
| 09/14/2000 | CA2362670A1 Matriptase, a serine protease and its applications |
| 09/14/2000 | CA2362422A1 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/14/2000 | CA2361699A1 A vessel for mixing a cell lysate |
| 09/13/2000 | EP1035206A1 Astaxanthin Synthetase |
| 09/13/2000 | EP1035204A1 Steroid hormone binding protein |
| 09/13/2000 | EP1035202A2 A cloning method for DNA fragments using arbitrarily primed PCR |
| 09/13/2000 | EP1035133A2 Fusion proteins comprising carriers that can induce a dual immune response |
| 09/13/2000 | EP1035129A1 A method of activating protein and an apparatus therefor |
| 09/13/2000 | EP1034788A1 Lactic acid bacteria strains capable of preventing diarrhea |
| 09/13/2000 | EP1034787A1 Lactobacillus strains preventing diarrhea caused by pathogenic bacteria |
| 09/13/2000 | EP1034786A1 Method for delivering direct feed microorganisms to poultry in ovo |
| 09/13/2000 | EP1034785A2 Hepatitis C virus diagnostics and vaccines |
| 09/13/2000 | EP1034428A1 Method and device for disintegrating biological cells for the purpose of extracting and analyzing cell contents |
| 09/13/2000 | EP1034308A1 Method of generating conditionally expressed mutant cells using expressible antisense sequences |
| 09/13/2000 | EP1034297A1 Murd protein and gene of staphylococcus aureus |
| 09/13/2000 | EP1034296A1 ribH POLYPEPTIDES AND POLYNUCLEOTIDES |
| 09/13/2000 | EP1034295A1 ribA |
| 09/13/2000 | EP1034282A1 Suicide expression vector for vaccine strains |
| 09/13/2000 | EP1034278A1 Method for the production of glycerol by recombinant organisms |
| 09/13/2000 | EP1034276A1 Novel era |
| 09/13/2000 | EP1034273A1 Histamine and serotonin binding molecules |
| 09/13/2000 | EP1034272A1 A cDNA ENCODING C6 $g(b)-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN |
| 09/13/2000 | EP1034266A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof |
| 09/13/2000 | EP1034265A1 Human cdc10 homolog |
| 09/13/2000 | EP1034260A2 Novel dna cloning method relying on the e. coli rece/rect recombination system |
| 09/13/2000 | EP1034259A1 Cloning method by multiple digestion, vectors for implementing same and applications |
| 09/13/2000 | EP1034253A1 Gram negative coccoid bacterium |
| 09/13/2000 | EP1034004A1 Recombinant mycoplasma hyopneumoniae vaccine |
| 09/13/2000 | EP1033993A1 Use of the e.coli strain dsm 6601 for treating diarrhoea in veterinary medicine |
| 09/13/2000 | EP1033910A1 Dipeptide apoptosis inhibitors and the use thereof |
| 09/13/2000 | EP0938557B1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 09/13/2000 | EP0772624B1 Interleukin-15 |
| 09/13/2000 | EP0733059B1 Compounds and methods for site-directed mutations in eukaryotic cells |
| 09/13/2000 | CN1266351A Control of enterohemorrhagic E Coli 0157 : H7 in cattle by probiotic bacteria |
| 09/13/2000 | CN1266101A Astaxanthin synthetic enzyme |
| 09/13/2000 | CN1056407C Live bacteria preparation containing Bacillus subtilis and its application in treatment of burns |
| 09/13/2000 | CN1056382C Improved HCV diagnostic agents |
| 09/12/2000 | US6118050 Nucleic acid which encodes polypeptide of defined amino acid sequence; transgenic cells and seeds; for screening herbicides |
| 09/12/2000 | US6117989 Human calcium-binding proteins |
| 09/12/2000 | US6117975 Amino acid and nucleotide sequences; for therapy |
| 09/12/2000 | US6117669 Nucleotide sequence coding an enzymatic polypeptide |
| 09/12/2000 | US6117668 Beauvericin detoxification compositions and methods |
| 09/12/2000 | US6117659 Recombinant narbonolide polyketide synthase |
| 09/12/2000 | US6117653 Hepatitis B surface antigen vaccine |
| 09/12/2000 | US6117652 Production of proteins by cell culture |
| 09/12/2000 | US6117651 Genetically engineered nucleic acid sequences linked to bacterial promoter and code heterologous polypeptides; for expressing a desired polypeptide in bacterial cells at high levels |
| 09/12/2000 | US6117649 Genetically engineered yeast strains |
| 09/12/2000 | US6117639 Screening for enzyme inhibitors against proteases, determining inhibitory activity; novel transcriptional assay using DNA molecules encoding the fusion protein substrates; Hepatitis C Virus NS3 protease or HIV aspartyl protease |
| 09/12/2000 | US6117424 Compositions of mononuclear phagocytes useful for promoting axonal regeneration |
| 09/12/2000 | US6117422 Genetic engineering |
| 09/12/2000 | CA2051375C Process and compositions for the isolation of human relaxin |
| 09/12/2000 | CA2021762C Antigens and methods therefor |
| 09/12/2000 | CA1341096C Cloning and use of the transaminase geme tyrb |
| 09/12/2000 | CA1341095C Cdna coding for the human von willebrand factor, plasmids or phages with such a cdna coding or fragments thereof respectively, micro-organisms and animal or human cell which contain such plasmids or phages, preparation of proteins by the cultivation of the above mentioned hosts, the obtained proteins and pharmaceutical compositions containing a biologically |
| 09/08/2000 | WO2000052180A1 Methods for generating and screening novel metabolic pathways |
| 09/08/2000 | WO2000052178A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
| 09/08/2000 | WO2000052177A1 Β-primeverosidase gene |
| 09/08/2000 | WO2000052174A1 Sakuranetin synthase gene |
| 09/08/2000 | WO2000052170A1 PHENOL-INDUCED PROTEINS OF $i(THAUERA AROMATICA) |
| 09/08/2000 | WO2000052163A1 Cloning of cdna of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer |
| 09/08/2000 | WO2000052141A1 Cells resistant to toxic genes and uses thereof |
| 09/08/2000 | WO2000052140A1 Assays for inhibitors of ftsh |
| 09/08/2000 | WO2000052139A1 Culture of mycobacteria |
| 09/08/2000 | WO2000052138A1 Biotechnological method for producing n-acetyl mannosamine |
| 09/08/2000 | WO2000052135A2 Engineering intracellular sialylation pathways |
| 09/08/2000 | WO2000052030A1 Rflat-1: a transcription factor that activates rantes gene expression |
| 09/08/2000 | WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b) |
| 09/08/2000 | WO2000052027A1 Compositions and methods for use in recombinational cloning of nucleic acids |
| 09/08/2000 | WO2000051435A1 Biological compositions and methods for enhancing plant growth and health and producing disease-suppressive plants |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000022139A9 Dna sequences for enzymatic synthesis of polyketide or heteropolyketide compounds |
| 09/08/2000 | WO2000018212A9 Platelet-derived growth factor c, dna coding therefor, and uses thereof |
| 09/08/2000 | WO2000015853A9 Recombinant newcastle disease virus rna expression systems and vaccines |
| 09/08/2000 | WO2000012720A3 Elongase genes and uses thereof |
| 09/08/2000 | WO2000012702A3 Human genes differentially expressed in colorectal cancer |
| 09/08/2000 | WO2000009709A3 Proteases and associated proteins |
| 09/08/2000 | WO2000009697A3 Pesticidal toxins and genes from bacillus laterosporus strains |
| 09/08/2000 | WO1999064595A9 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME |
| 09/08/2000 | WO1999049019A8 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 09/08/2000 | WO1999015650A9 Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna |
| 09/08/2000 | CA2366059A1 Cloning of cdna of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer |
| 09/08/2000 | CA2364579A1 Culture of mycobacteria |
| 09/08/2000 | CA2364384A1 Assays for inhibitors of ftsh |
| 09/08/2000 | CA2363924A1 Compositions and methods for use in recombinational cloning of nucleic acids |
| 09/08/2000 | CA2362989A1 Methods for generating and screening novel metabolic pathways |
| 09/08/2000 | CA2360935A1 Phenol-induced proteins of thauera aromatica |